Back
Day Range
$122.22
$126.99
52-Week Range
$68.70
$155.53
Volume
1,308,771
50D / 200D Avg
$131.49
/
$113.06
Prev Close
$124.33
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 22.3 | 0.4 |
| P/B | 7.0 | 2.9 |
| ROE % | 33.4 | 3.8 |
| Net Margin % | 19.6 | 3.9 |
| Rev Growth 5Y % | -1.0 | 10.0 |
| D/E | 0.9 | 0.2 |
Key Takeaways
Revenue declined -1.03% annually over 5 years
ROE of 33.36% indicates high profitability
Net margin of 19.58% shows strong profitability
Generating 931.00M in free cash flow
Cash machine — converts 109.53% of earnings into free cash flow
Capital efficient — spends only 3.41% of revenue on capex
Growth
Revenue Growth (5Y)
-1.03%
Revenue (1Y)-0.69%
Earnings (1Y)N/A
FCF Growth (3Y)81.70%
Quality
Return on Equity
33.36%
ROIC12.30%
Net Margin19.58%
Op. Margin19.92%
Safety
Debt / Equity
0.94
Current Ratio2.08
Interest Coverage8.65
Valuation
P/E Ratio
22.27
P/B Ratio6.95
EV/EBITDA23.19
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0.69% | Revenue Growth (3Y) | -1.81% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -1.03% | Earnings Growth (5Y) | 2.77% |
| Profitability | |||
| Revenue (TTM) | 4.34B | Net Income (TTM) | 850.00M |
| ROE | 33.36% | ROA | 12.79% |
| Gross Margin | 66.49% | Operating Margin | 19.92% |
| Net Margin | 19.58% | Free Cash Flow (TTM) | 931.00M |
| ROIC | 12.30% | FCF Growth (3Y) | 81.70% |
| Safety | |||
| Debt / Equity | 0.94 | Current Ratio | 2.08 |
| Interest Coverage | 8.65 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 22.27 | P/B Ratio | 6.95 |
| P/S Ratio | 4.36 | PEG Ratio | -0.14 |
| EV/EBITDA | 23.19 | Dividend Yield | 0.00% |
| Market Cap | 18.93B | Enterprise Value | 20.06B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.34B | 4.37B | 4.50B | 4.58B | 4.53B |
| Net Income | 850.00M | -1.22B | -1.16B | -4.40B | 762.00M |
| EPS (Diluted) | 5.44 | -7.69 | -7.35 | -28.05 | 5.05 |
| Gross Profit | 2.89B | 2.86B | 2.74B | 2.97B | 3.15B |
| Operating Income | 865.00M | -833.00M | -1.07B | -4.18B | -123.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6.64B | 6.30B | 10.11B | 12.25B | 15.22B |
| Total Liabilities | 3.92B | 3.93B | 4.37B | 5.65B | 4.48B |
| Shareholders' Equity | 2.72B | 2.37B | 5.75B | 6.60B | 10.74B |
| Total Debt | 2.55B | 2.62B | 2.26B | 3.56B | 2.54B |
| Cash & Equivalents | 1.42B | 1.13B | 1.05B | 2.01B | 1.23B |
| Current Assets | 3.29B | 2.75B | 2.61B | 3.56B | 2.71B |
| Current Liabilities | 1.59B | 1.55B | 1.57B | 2.77B | 1.09B |